David Hausmann

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol.

SENIPERA Phase 0/1 randomized window-of-opportunity clinical trial of SENIcapoc and PERAmpanel mono- and combination therapy of newly diagnosed glioblastoma: a trial protocol.

Journal: BMC cancer
Published: November 25, 2025

Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research.

Development of a fully human glioblastoma-in-brain-spheroid model for accelerated translational research.

Journal: Journal of advanced research
Published: February 15, 2025

Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models.

Disrupting glioblastoma networks with tumor treating fields (TTFields) in in vitro models.

Journal: Journal of neuro-oncology
Published: June 04, 2024

Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression.

Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression.

Journal: Cancer discovery
Published: March 22, 2024

Recording physiological history of cells with chemical labeling.

Recording physiological history of cells with chemical labeling.

Journal: Science (New York, N.Y.)
Published: February 22, 2024

A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1.

A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1.

Journal: Nature communications
Published: January 25, 2023

Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765).

Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765).

Journal: BMJ open
Published: October 31, 2022

Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.

Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.

Journal: International journal of molecular sciences
Published: March 31, 2022

Autonomous rhythmic activity in glioma networks drives brain tumour growth.

Autonomous rhythmic activity in glioma networks drives brain tumour growth.

Journal: Nature
Published: February 04, 2021

Correction: Ionic-liquid-assisted synthesis of the phosphorus interhalides [PBr4][IBr2] and [PBr4][I5Br7].

Correction: Ionic-liquid-assisted synthesis of the phosphorus interhalides [PBr4][IBr2] and [PBr4][I5Br7].

Journal: Dalton transactions (Cambridge, England : 2003)
Published: April 12, 2017

Ionic-liquid-assisted synthesis of the phosphorus interhalides [PBr4][IBr2] and [PBr4][I5Br7].

Ionic-liquid-assisted synthesis of the phosphorus interhalides [PBr4][IBr2] and [PBr4][I5Br7].

Journal: Dalton transactions (Cambridge, England : 2003)
Published: October 07, 2016

Bromine-rich Zinc Bromides: Zn6Br12(18-crown-6)2×(Br2)5, Zn4Br8(18-crown-6)2×(Br2)3, and Zn6Br12(18-crown-6)2×(Br2)2.

Bromine-rich Zinc Bromides: Zn6Br12(18-crown-6)2×(Br2)5, Zn4Br8(18-crown-6)2×(Br2)3, and Zn6Br12(18-crown-6)2×(Br2)2.

Journal: Inorganic chemistry
Published: June 10, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026